Cernostics
Latest round
- Series B
Last raised
- Jul 2013
Total raised
- $4M
Investors
- 3
About Cernostics
Cernostics, Inc.Cernostics, Inc. is a diagnostic company located in Pittsburgh, US that focuses on providing diagnostic tests for cancer risk assessment.000 mn in cash and stock on October 19, 2021. The transaction was finalized in December 2021.Cernostics, through its flagship product TissueCypher, offers an AI-driven precision medicine test designed to assess the risk of progression from Barrett’s esophagus (BE) to esophageal adenocarcinoma (EAC). TissueCypher analyzes tissue samples from standard BE pinch biopsies using proprietary algorithms to produce an individualized five-year risk score, thus aiding healthcare providers in making informed clinical decisions.Cernostics generates revenue primarily through its laboratory-developed tests, particularly TissueCypher, which are ordered by physicians for their patients. This model streamlines patient management in relation to esophageal cancer risk. Revenue is derived from test orders, facilitating healthcare providers in making clinical decisions.000 mn from the TRADE SALE to support further development of innovative products and expand its market reach. Plans include launching new diagnostic tests and expanding operations into additional geographic regions, specifically targeting growth in the oncology market. Further details on specific products or timelines for market expansion have yet to be disclosed.
Who invested in Cernostics
3 investors across 2 rounds
See all investors in Cernostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cernostics
Who invested in Cernostics?
Cernostics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cernostics raised?
Cernostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cernostics last raise money?
Cernostics's most recent round on record is a Series B, in Jul 2013.
What does Cernostics do?
Cernostics is a healthcare specialists company.
Where is Cernostics headquartered?
Cernostics is headquartered in Pittsburgh, US.
Which VCs invest in companies like Cernostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Cernostics's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Cernostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.